/Investor DB

PureTech Health — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

Vor Biopharmavorbio.comNASDAQ: VORJun 2020

Vor Biopharma is a biopharmaceutical company.

BiotechCambridge, US

Nathan Jorgensen(Executive Officer)Amy Mendel(Executive Officer)Robert Ang(Executive Officer, Director)Jean-Paul Kress(President, Chief Executive Officer and Chairman of the Board)in

BoardKush Parmar(Director)inJoshua Resnick(Director)

Co-investors5AM VenturesOUP (Osage University Partners)RA Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.